NCT05906862View on ClinicalTrials.gov

AMT-253 in Patients With Selected Advanced Solid Tumours

PHASE1RecruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

November 6, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

December 30, 2026

Conditions
Advanced Solid Tumor
Interventions
DRUG

AMT-253

Administered intravenously

Trial Locations (7)

Unknown

RECRUITING

Blacktown, Sydney

RECRUITING

Chris O'Brien Lifehouse, Sydney

RECRUITING

Maquarie University Hospital, Sydney

RECRUITING

ICON Cancer Centre, Brisbane

RECRUITING

Southern Oncology Clinical Research, Adelaide

RECRUITING

Cabrini Malvern Hospital, Malvern

VIC 3004

RECRUITING

Alfred Hospital, Melbourne

All Listed Sponsors
lead

Multitude Therapeutics (Australia) Pty Ltd

INDUSTRY